Recognizing and treating Raynaud phenomenon.

Kristen Thoelen, Kimberly Maiers, Kristy-Ann Bondi, Jean Covino

Journal: JAAPA : official journal of the American Academy of Physician Assistants 2016;28(11):40-4

PMID: 26501577

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Raynaud phenomenon is an episodic ischemia caused by cold, emotional stimuli, or rheumatologic disorders, and is more common in women than men. This article describes the clinical presentation of Raynaud phenomenon and how to diagnose and appropriately treat patients and prevent complications. Research on the use of different pharmacologic interventions for Raynaud phenomenon is ongoing and treatment options are expanding.

Address: Kristen Thoelen, Kimberly Maiers, and Kristy-Ann Bondi are graduates of the PA program at Pace University Lenox Hill Hospital in New York City. Jean Covino is an associate clinical professor at Pace University Lenox Hill Hospital. The authors have disclosed no potential conflicts of interest, financial or otherwise.

DOI: 10.1097/01.JAA.0000471610.61784.da

Link outs

Free resources

Medical:

https://medlineplus.gov/raynaudphenomenon.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Blood Sedimentation, Calcium Channel Blockers, Humans, Life Style, Phosphodiesterase 5 Inhibitors, Physical Examination, Prostaglandins, Synthetic, Protective Clothing, Raynaud Disease, Selective Serotonin Reuptake Inhibitors